Premium cannabis brand Orchid Ventures, Inc. (CSE:ORCD, OTC:ORVRF) (“Orchid Ventures” or the “Company”) today released its consolidated financial results for the fiscal year end 2019. All financial information for the period ended May 31, 2019 is reported in US dollars, unless otherwise indicated.

“We are making steady progress on our revenue generating strategic priorities while simultaneously remaining vigilant of our commitment to our customers, our shareholders and our employees. We remain focused on creating the highest standards in cannabis and creating safe, quality products while maintaining a low cost profile. We are proud to present our year end results and continue to improve our trajectory as a Company. I am motivated by our team’s dedication and hard-work to date, and excited for the acquisitions that have been made so far in fiscal year 2020.” says Corey Mangold, CEO & Founder of Orchid Ventures


FINANCIAL COMMENTARY:

The net assets of the Company improved significantly from 2018. Net assets increased from a deficiency of $633,947 at May 31, 2018 to $2,933,140 at May 31, 2019, an increase of $3,567,087.

Working capital as at May 31, 2019 was $2,580,475, a significant improvement from the year prior’s deficiency of $690,465. The increase in working capital is mostly attributed to a 53% increase in the Company’s trade receivables.

Revenue increased by $3 million (or 123%) from $2.5 million to $5.5 million for the year ended May 31, 2019. The increase in sales were from expanding into California in January 2019.

Gross profit for the year ended May 31, 2019 increased to $1,973,118 (36% of revenues) compared to $1,256,918 for the year ended May 31, 2018 (51% of revenues). Gross profit decreased due to lower margins being realized in the California market as well as specific pricing reductions in Oregon. In addition, the Company has written down a portion of its older inventory that was purchased in 2019 that was included in cost of sales.

Operating expenses from ongoing operations for the Company increased by 63%, or by $1.82 million. The increase in costs is a result of the Company’s focused expansion in the Oregon cannabis market. Other reasons include costs associated with the reverse take-over and listing on the CSE, and costs associated with the regulatory environment of being a new publicly traded entity. Furthermore, the Company’s expansion required significant expenditures in compensation costs, administrative, and rent and utilities.

The Company’s net loss from ongoing operations increased from $1.7 million in 2018 to $2.35 million in 2019. Net loss from ongoing operations excludes non-cash items such as share-based payment and listing expenses, which totaled $4.3 million.

2019 HIGHLIGHTS

  • Launched line of Orchid Essentials products in California and revenue increased by 123%, from $2.5 million in 2018 to $5.5 million in 2019.
  • Launched 9 new SKU’s which also helped drive new customers and new sales
  • Acquired Forrest Green Distribution in Long Beach, CA with a BCC Type-11 provisional distribution license
  • Acquired a distribution license with light manufacturing in Clackamas, OR
  • Began filling cartridges and finished goods packaging in Oregon which led to a reduction in costs
  • Listed on the CSE (CSE:ORCD) through a reverse takeover (RTO) of Earny Resources
  • Management team changes and formation of a Board of Directors including independents Tom Soto & Robert MacDonald

ADDITIONAL INFORMATION

Additional information relating to the Company’s fiscal year end 2019 results is available on SEDAR at www.sedar.com in the Company’s Interim Financial Statements and Management Discussion & Analysis (“MD&A”) for the year.

The Company will hold an earnings call on Thursday, October 17th at 10am PT (1pm ET). Individuals interested in listening to the conference call may do so by dialing (844) 407-9500 for domestic calls or (862) 298-0850 for international calls. To listen to a live webcast, please visit: https://www.investornetwork.com/event/presentation/53829.

The call will provide details surrounding the recently released financial statements and provide an opportunity for Q&A.

A replay of the call will be available until October 24th, 2019. To access the replay, dial (877) 481-4010 for domestic calls or (919) 882-2331 for international calls. The replay passcode is 53829. The webcast will be available until January 17th, 2019 at https://www.investornetwork.com/event/presentation/53829.

ABOUT ORCHID ESSENTIALS

Orchid Essentials is an Irvine, CA based multi-state operator that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium cannabis products. Orchid’s product lines are currently sold in 350+ dispensaries across California and Oregon and are handcrafted and designed for optimal user-experience and overall enjoyment. The company’s proven processes and passion for what it does carry through into its products. The end result is an unparalleled experience for new and practiced cannabis users alike. Orchid plans to expand its operations into new national markets, as well as global markets such as Latin America and Europe. With a continued focus on brand and intellectual property development, Orchid will continue to execute strategic acquisitions to further solidify it’s vertically integrated infrastructure with the goal of becoming a dominant premium cannabis company in the United States. Orchid’s management brings significant branding, product development and distribution experience with a proven track record of scaling revenues, building value-generating partnerships and creating enterprise value. Learn more at https://orchidessentials.com/.

ON BEHALF OF THE BOARD OF DIRECTORS – ORCHID VENTURES, INC.

Corey Mangold
CEO and Director
investors@orchidessentials.com

Investor Relations

Antonio Cruz
(949) 769-3859
a.cruz@orchidventures.com

The CSE does not accept responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding “Forward-Looking” Information

This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word “will” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon.. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct. The Company does not undertake to update these forward-looking statements, except as required by law.

Safe Harbor Statement

Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials any of its affiliates or subsidiaries (collectively, the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company’s ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company’s Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Click here to connect with Orchid Ventures Inc. (CSE:ORCD) for an Investor Presentation.

Source

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less